Global Information
회사소개 | 문의 | 위시리스트

이식형 의약품 주입펌프 : 의료기기 파이프라인 평가

Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 05월 상품 코드 358889
페이지 정보 영문 37 Pages
가격
US $ 2,500 ₩ 2,988,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,977,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,965,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


이식형 의약품 주입펌프 : 의료기기 파이프라인 평가 Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 05월 페이지 정보 : 영문 37 Pages

현재 개발중인 이식형 의약품 주입펌프(Implantable Infusion Pumps)의 파이프라인 제품 정보에 대해 조사 분석했으며, 주요 제품과 프로젝트, 주요 기업, 임상시험 정보, 최근 동향 등의 정보를 전해드립니다.

제1장 목차

제2장 서론

  • 이식형 의약품 주입펌프 개요

제3장 개발중인 제품

  • 이식형 의약품 주입펌프 - 파이프라인 제품 : 개발 단계별
  • 이식형 의약품 주입펌프 - 파이프라인 제품 : 지역별
  • 이식형 의약품 주입펌프 - 파이프라인 제품 : 규제 경로별
  • 이식형 의약품 주입펌프 - 파이프라인 제품 : 승인 시기별(예정)

제4장 이식형 의약품 주입펌프 : 개발중인 파이프라인 제품(기업별)

  • 이식형 의약품 주입펌프 기업 - 파이프라인 제품 : 개발 단계별
  • 이식형 의약품 주입펌프 - 파이프라인 제품 : 개발 단계별

제5장 이식형 의약품 주입펌프 기업과 제품 개요

  • Alnylam Pharmaceuticals, Inc.
  • Debiotech S.A.
  • Delpor, Inc.
  • Eksigent Technologies, LLC
  • Eli Lilly and Company
  • Flowonix Medical, Inc.
  • FluidSynchrony, LLC
  • Intarcia Therapeutics, Inc.
  • Medallion Therapeutics, Inc.
  • Nano Precision Medical
  • Pharmaco-Kinesis Corporation
  • University of Minnesota
  • University of Southern California

제6장 이식형 의약품 주입펌프 : 최근 동향

제7장 부록

도표

LSH 16.06.14

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • Table 2: Implantable Infusion Pumps - Pipeline Products by Territory
  • Table 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
  • Table 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
  • Table 5: Implantable Infusion Pumps - Ongoing Clinical Trials
  • Table 6: Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
  • Table 7: Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • Table 8: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: MIP Implantable Pump - Product Status
  • Table 10: MIP Implantable Pump - Product Description
  • Table 11: Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Implantable Drug Delivery System - Product Status
  • Table 13: Implantable Drug Delivery System - Product Description
  • Table 14: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Drug Delivery System - Parkinson's Disease - Product Status
  • Table 16: Drug Delivery System - Parkinson's Disease - Product Description
  • Table 17: Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Prometra II Programmable Infusion System - ICV - Product Status
  • Table 19: Prometra II Programmable Infusion System - ICV - Product Description
  • Table 20: Flowonix Medical Inc - Ongoing Clinical Trials Overview
  • Table 21: Prometra II Programmable Infusion System - ICV - A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects with Focal Seizures, with Temporal Lobe Onset with or without Secondary Generalization
  • Table 22: InBrain Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Dopamine Infusion Pump - Product Status
  • Table 24: Dopamine Infusion Pump - Product Description
  • Table 25: Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: ITCA 650 Osmotic Pump - Product Status
  • Table 27: ITCA 650 Osmotic Pump - Product Description
  • Table 28: Omega DUROS - Product Status
  • Table 29: Omega DUROS - Product Description
  • Table 30: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Implantable Micro - Cannula Device - Product Status
  • Table 32: Implantable Micro - Cannula Device - Product Description
  • Table 33: MiNDS - Product Status
  • Table 34: MiNDS - Product Description
  • Table 35: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: ALN-HTT Infusion System - Product Status
  • Table 37: ALN-HTT Infusion System - Product Description
  • Table 38: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Infusion Micropump - Product Status
  • Table 40: Infusion Micropump - Product Description
  • Table 41: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Drug Infusion Pump - Product Status
  • Table 43: Drug Infusion Pump - Product Description
  • Table 44: Glossary

List of Figures

  • Figure 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • Figure 2: Implantable Infusion Pumps - Pipeline Products by Territory
  • Figure 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
  • Figure 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
  • Figure 5: Implantable Infusion Pumps - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2019" provides an overview of Implantable Infusion Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Implantable Infusion Pumps under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Infusion Pumps under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Implantable Infusion Pumps Overview

3 Products under Development

  • 3.1 Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • 3.2 Implantable Infusion Pumps - Pipeline Products by Territory
  • 3.3 Implantable Infusion Pumps - Pipeline Products by Regulatory Path
  • 3.4 Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
  • 3.5 Implantable Infusion Pumps - Ongoing Clinical Trials

4 Implantable Infusion Pumps - Pipeline Products under Development by Companies

  • 4.1 Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
  • 4.2 Implantable Infusion Pumps - Pipeline Products by Stage of Development

5 Implantable Infusion Pumps Companies and Product Overview

  • 5.1 Debiotech SA Company Overview
  • 5.2 Eksigent Technologies LLC Company Overview
  • 5.3 Eli Lilly and Co Company Overview
  • 5.4 Flowonix Medical Inc Company Overview
  • 5.5 InBrain Pharma SAS Company Overview
  • 5.6 Intarcia Therapeutics Inc Company Overview
  • 5.7 Massachusetts Institute of Technology Company Overview
  • 5.8 Medtronic plc Company Overview
  • 5.9 University of Minnesota Company Overview
  • 5.10 University of Southern California Company Overview

6 Implantable Infusion Pumps- Recent Developments

  • 6.1 Feb 11, 2019: Summit Medical expands manufacturing operations with the addition of new St. Paul facility
  • 6.2 Feb 05, 2019: Flowonix receives FDA approval for software upgrade designed to improve user experience
  • 6.3 Jan 18, 2019: Medtronic begins enrolment in pain pump trial
  • 6.4 Oct 24, 2018: FDA approves new SynchroMed II myPTM Personal Therapy Manager that enables patients to alleviate unpredictable pain
  • 6.5 Oct 16, 2018: Medtronic launches the control workflow to help eliminate oral opioids and provide effective pain relief
  • 6.6 Aug 16, 2018: Treatment with ITB Therapy vs. Oral Medication shows quality of life improvement, reduction in spasticity-related pain
  • 6.7 Aug 01, 2018: Medtronic receives FDA nod for Implantable System for Remodulin

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top
전화 문의
F A Q